Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19

BACKGROUND: The clinical management of coronavirus disease 2019 (COVID-19) is dependent on understanding the underlying factors that contribute to the disease severity. In the absence of effective antiviral therapies, other host immunomodulatory therapies such as targeting inflammatory response are...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, De, Zhao, Peng, Zhang, Dawei, Dong, Jing-Hui, Xu, Zhe, Yang, Guang, Li, Bo-Yu, Liu, Hong-Xia, Li, Bo-An, Qin, Cheng-Feng, Peng, Xiao-Hua, Wang, Fu-Sheng, Xie, Li-Xin, Chen, Zhu, Dela Cruz, Charles S., Sharma, Lokesh, Qin, En-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305869/
https://www.ncbi.nlm.nih.gov/pubmed/32574840
http://dx.doi.org/10.1016/j.jaip.2020.06.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305869/
https://www.ncbi.nlm.nih.gov/pubmed/32574840
http://dx.doi.org/10.1016/j.jaip.2020.06.015

Ejemplares similares